Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion type Assertion NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_head.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion description "[In the majority of classic MPN--polycythemia vera, essential thrombocythemia, and primitive myelofibrosis--driver oncogenic mutations affecting Janus kinase 2 (JAK2) or MPL lead to constitutive activation of cytokine-regulated intracellular signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion evidence source_evidence_literature NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion SIO_000772 21653328 NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion wasDerivedFrom befree-20140225 NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion wasGeneratedBy ECO_0000203 NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.